The importance of pulmonary rehabilitation in patients with COVID-19
DOI:
https://doi.org/10.33233/fb.v22i2.4288Keywords:
coronavirus infection; betacoronavirus; physical and rehabilitation medicineAbstract
Introduction: A highly infectious disease of the respiratory tract, coronavirus disease 2019 (COVID-19) can cause respiratory, physical and psychological dysfunction in patients. Therefore, pulmonary rehabilitation is crucial for patients admitted and discharged from COVID-19. The long-term sequelae of COVID-19 are unknown, but evidence of previous CoV outbreaks demonstrates impaired lung and physical function, reduced quality of life and emotional distress. Method: This is a systematic review of the literature carried out through digital bibliographic search of scientific articles published in printed and electronic journals, clinical trials, randomized studies, systematic reviews, in the period between the years 2003 and 2020. Results: Many survivors of COVID-19 that require critical care can develop psychological, physical and cognitive impairments. Conclusion: There is a clear need for guidance on the rehabilitation of COVID-19 survivors.
References
Sonja A. Rasmussen, MD, MS JCS. Coronavirus disease 2019 (COVID-19) and pregnancy. Responding to a rapidly evolving situation. Ann Oncol 2020;19-21. doi: 10.1016/j.ajog.2020.02.017
Singhal T. A Review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020;87(4):281-6. doi: 10.1007/s12098-020-03263-6
Mahmudpour M, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: The anger of inflammation. Cytokine 2020. doi: 10.1016/j.cyto.2020.155151
Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health 2020;25(3):278-80. doi: 10.1111/tmi.13383
Rothan HA, Byrareddy SN. The epidemeology and pathogensis of coronavirus (Covid-19) outbreak. J Autoimmun 2020;109:1-4. doi: 10.1016/j.jaut.2020.102433
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-NCOV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382(10):970-1. doi: 10.1056/NEJMc2001468
Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. 2020;21(5):343-60. doi: 10.1631/jzus.B2000083
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet Respiratory Medicine 2020; 8(4):420-2, doi: 10.1016/S2213-2600(20)30076-X.
He F, Deng Y, Li W. Coronavirus disease 2019 : What we know ? 2020;(3):719-25. doi: 10.1002/jmv.25766
Wang D, Hu Bo, Hu Chang. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama 2020;1-9. doi: 10.1001/jama.2020.1585
Wu Z, McGoogan J. Characteristics of and important lessons from the coronavirus disease 2019 ( COVID-19 ) outbreak in China summary of a report of 72 314 cases from the chinese center for disease control and prevention 2020. Jama 2019;323(13):1239-42. doi: 10.1001/jama.2020.2648
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M., et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med 2020;8(5):518-26. doi: 10.1016/S2213-2600(20)30121-1
Minhas AS, Scheel P, Garibaldi B, Liu G, Horton M, Jennings M, et al. Takotsubo Syndrome in the Setting of COVID-19. JACC Case Rep 2020;2(9):1321-25. doi: 10.1016/j.jaccas.2020.04.023
Bulut C, Kato Y. Epidemiology of covid-19. Turkish J Med Sci 2020;50(SI-1):563-70. doi: 10.3906/sag-2004-172
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032
Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005;60(5):401-9. doi: 10.1136/thx.2004.030205
Robinson CC, Rosa RG, Kochhann R, Schneider D, Sganzerla D, Dietrich C, et al. Quality of life after intensive care unit: A multicenter cohort study protocol for assessment of long-term outcomes among intensive care survivors in Brazil. Rev Bras Ter Intensiva 2018;30(4):405-13. doi: 10.5935/0103-507x.20180063
Razzaque MS, Taguchi T. Pulmonary fibrosis: cellular and molecular events. Pathol Int 2003;53(3):133-45. doi: 10.1046/j.1440-1827.2003.01446.x
Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 2005;75(2):185-94. doi: 10.1002/jmv.20255
Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep 2020;22(5):32. doi: 10.1007/s11886-020-01292-3
Berger JR. COVID-19 and the nervous system. J Neurovirol 2020. https://doi.org10.1007/s13365-020-00840-5
Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;bjsports-2020-102596. doi: 10.1136/bjsports-2020-102596
Chan KS, Zheng JP, Mok YW, Li YM, Liu YN, Chu CM, et al. SARS: Prognosis, outcome and sequelae. Respirology 2003;8:36-40. doi: 10.1046/j.1440-1843.2003.00522.x
Ong KC, Ng AWK, Lee LSU, Kaw G, Kwek SK, Leow MKS, et al. 1-Year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest 2005;128(3):1393-400. doi: 10.1378/chest.128.3.1393
Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005;128(4):2247-61. https:/doi.org/10.1378/chest.128.4.2247
Lau HMC, Lee EWC, Wong CNC, Ng GYF, Jones AYM, Hui DSC. The impact of severe acute respiratory syndrome on the physical profile and quality of life. Arch Phys Med Rehabil 2005;86(6):1134-40. doi: 10.1016/j.apmr.2004.09.025
Vos T, Abajobir AA, Abbafati C, Abbas KM, Abate KH, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390(10100):1211–59. doi: 10.1016/S0140-6736(17)32154-2
Spruit MA, Singh SJ, Garvey C, Zu Wallack R, Nici L, Rochester C, et al. An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8). doi: 10.1164/rccm.201309-1634ST.
Yang L-L, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med 2020;6(2):79-86. doi: 10.1016/j.cdtm.2020.05.002
Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020;39:101166. doi: 10.1016/j.ctcp.2020.101166.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 2020;12(1):69. doi: 10.1186/s13195-020-00640-3
Published
Issue
Section
License
Copyright (c) 2021 Paula Lima Bosi, Luciana Fernanda de Freitas Januzzi, Priscila Barreto de Paula, Camila Carvalho de Oliveira, Claudio Alvin Scianni, Thais Aparecida Nunes da Costa, Claudia Teixeira Monteiro de Freitas Teixeira, Raphael Borges de Oliveira Gomes, Adriano Santos Clovis, Giselle Aline dos Santos Gonçalves, Paulo Henrique Silva Maia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
